Healthcare & Life Sciences
AmCham Germany discusses current healthcare policies in its Healthcare and Life Sciences Committee. The committee represents the interests of all healthcare industries within AmCham Germany’s membership. Ranging from pharmaceutical research companies to medical technology and diagnostics as well as IT firms and the consumer health sector, the committee’s mission is to speak with one voice for the entire healthcare sector.
It addresses current healthcare topics and engages in stakeholder discussions on the future of the German healthcare market. The committee maintains a clear, constructive and open dialogue with all relevant policy and decision-makers on the regional and federal level as well as on the European level depending on the issues. All major developments are monitored closely. The Healthcare and Life Sciences Committee focuses on regulatory issues related to healthcare and pharmaceutical products and seeks to promote a less regulated market, a friendlier investment climate, and further research opportunities within Germany.
Note: Until June 2017, the Healthcare and Life Sciences Committee consisted of two committees: Healthcare and Business of Healthcare.
2021
February 22, 2021: Healthcare & Life Sciences Virtual Committee Meeting
with Stephan Pilsinger, MdB, member of the Committee of Health, CDU/CSU Parliamentary Group
Topic: Current Health Policy Issues
May 19, 2021: Healthcare & Life Sciences Committee Meeting
with Wolfgang Tiefensee, Minister for Economy, Science and Digital Society of Thuringia
Topic: Thuringia as a Business Location for the Industrial Health Industry & intellectual property rights
June 15 2021: Healthcare & Life Sciences Committee Meeting
with Dr. Gesa Miehe-Nordmeyer, Head of the Department for Social Policy, Health, Labor Market, Environment and Social Politics, Federal Chancellery
Topic: Pharmaceutical Strategy for Europe, EU Action Plan against Antimicrobial Resistance, Intellectual Property Rights
2020
October 13, 2020: Virtual Healthcare & Life Sciences Committee Meeting
with Stephan Albani, MdB, Chairman of the CDU/CSU Parliamentary Group in the Committee on Education, Research and Technology Assessment
April 21, 2020: Virtual Healthcare & Life Sciences Committee Meeting
with Tino Sorge, MdB, Rapporteur Digitization and Healthcare Industry, CDU/CSU Parliamentary Group
Topic: Current corona situation and effects on the health care system
May 28, 2020: Virtual Healthcare & Life Sciences Committee Meeting
with Dr. Till Kaesbach, Head of EU Council Presidency Staff Unit, Federal Ministry of Health
Topic: German EU Council Presidency
June 24, 2020: Virtual Healthcare & Life Sciences Committee Meeting
with Maria Klein-Schmeink, MdB, Spokesperson for Health Policy, Alliance90/The Green Party Parliamentary Group
Topic: German EU Council Presidency, current health policy issues
2019
January 18, 2019: Healthcare & Life Sciences Committee Meeting
with Thomas Müller, Head of Department for Drugs, Medical Devices, Biotechnology, Federal Ministry of Health
February 11, 2019: Healthcare & Life Sciences Committee Meeting
with Prof. Dr. Andrew Ullmann, Member of the Health Committee, FDP parliamentary group
February 20, 2019: Healthcare & Life Sciences Committee Meeting
with Mark Hauptmann, Chairman of the “Junge Gruppe”, CDU/CSU parliamentary group and member of the group's executive committee
March 1, 2019: "Ländergespräch" Saxony
with Barbara Klepsch, Minister of State for Social Affairs and Consumer Protection, Saxon Ministry of State for Social Affairs and Consumer Protection
July 4, 2019: Healthcare & Life Sciences Committee Meeting
with Harald Kuhne, Head of Central Directorate General, Federal Ministry of Economic Affairs and Energy
July 30, 2019: "Ländergespräch" Baden-Wuerttemberg
with Günther Leßnerkraus, Head of Division 3 - Industry, Innovation and Business-oriented Research, Ministry of Economic Affairs of Baden-Wuerttemberg
September 3, 2019: Healthcare & Life Sciences Committee Meeting
with Martin Weiland, Head of Directorate 31: Head of the Social, Health and Labor Market Policy, German Chancellery
2018
April 18, 2018: Healthcare & Life Sciences Committee Meeting
with Stephan Pilsinger, Member of the Health Committee, CDU/CSU Parliamentray Group
August 15, 2018: "Ländergespräch" North Rhine-Westphalia
with Karl-Uwe Bütof, Director of Department IV: Innovation & Markets, Ministry of Economic Affairs of North Rhine-Westphalia
September 18, 2018: "Ländergespräch" Hesse
with Klaus-Dieter Jäger, Director of Department II: Economic Policy & Economic Promotion, Hessian Ministry of Economic Affairs
September 18, 2018: "Ländergespräch" Hesse
with Dr. Stephan Hölz, Director of Department V: Health, Hessian Ministry of Social Affairs and Integration
October 24, 2018: "Ländergespräch" Saarland
with Stefan Rauber, Director of Department F: Energy, Industry, and Services Policy, Ministry of Economic Affairs of Saarland
November 23, 2018: "Ländergespräch" Rhineland-Palatinate
with Dr. Michael Cramer, Director of Unit 633: Pharmaceutics, Rhineland-Palatinate Health Ministry, and Dr. Gerald Wiesch, Unit 8402: Telecommunications, Digitization of the Economy, Health Management, Innovation Centers, Rhineland-Palatinate Ministry of Economic Affairs
December 3, 2018: "Ländergespräch" Bavaria
with Dr.-Ing. Thomas Krammer, Director of Unit 41: Issues of Innovation and Technology Policy, Biotechnology, and Medical Technology, Bavarian Ministry of Economic Affairs
December 10, 2018: "Ländergespräch" Thuringia
with Wolfgang Tiefensee, Minister of Economic Affairs, Science, and Digital Society, Thuringian Ministry of Economic Affairs, Science, and Digital Society
Healthcare News
Healthcare & Life Sciences Committee
AmCham Germany discusses current healthcare policies in its Healthcare and Life Sciences Committee. The committee represents the interests of all healthcare industries within AmCham Germany’s membership.
Downloads
Stellungnahme: Ein Plädoyer für offene Märkte und pluralistische Strukturen Positionen der industriellen Gesundheitswirtschaft zur Gesundheitsversorgung
PDF912.18 KB